Cargando…

The role of epigenetics in kidney malignancies

INTRODUCTION: Renal cell carcinomas (RCC) are collectively the third most common type of genitourinary neoplasms, surpassed only by prostate and bladder cancer. Cure rates for renal cell carcinoma are related to tumor grade and stage; therefore, diagnostic methods for early detection and new therape...

Descripción completa

Detalles Bibliográficos
Autores principales:	la Rosa, Alfredo Harb-De, Acker, Matthew, Swain, Sanjaya, Manoharan, Murugesan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2015
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526599/ https://www.ncbi.nlm.nih.gov/pubmed/26251734 http://dx.doi.org/10.5173/ceju.2015.453

Ejemplares similares

Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder
por: La Rosa, Alfredo Harb-De, et al.
Publicado: (2015)

Pelvic lipomatosis: Bladder sparing extirpation of pelvic mass to relieve bladder storage dysfunction symptoms and pelvic pain
por: Ali, Ahmed, et al.
Publicado: (2014)

Operative technique and early experience for robotic-assisted laparoscopic nephroureterectomy (RALNU) using da Vinci Xi
por: Darwiche, Fadi, et al.
Publicado: (2015)

Robotic Partial Nephrectomy with the Da Vinci Xi
por: Kallingal, George J. S., et al.
Publicado: (2016)

The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer
por: Nieder, Alan M., et al.
Publicado: (2006)

Role of maximum androgen blockade in advanced prostate cancer
por: Ayyathurai, Rajinikanth, et al.
Publicado: (2009)

Epigenetic roles in the malignant transformation of gastric mucosal cells
por: Tie, Jun, et al.
Publicado: (2016)

Is Glioblastoma an Epigenetic Malignancy?
por: Maleszewska, Marta, et al.
Publicado: (2013)

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018)

Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells
por: Mahalingaiah, Prathap Kumar S., et al.
Publicado: (2016)

Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016)

Genomics and Epigenetics of Malignant Mesothelioma
por: Sage, Adam P., et al.
Publicado: (2018)

The Impact of Epigenetic Modifications in Myeloid Malignancies
por: Venney, Deirdra, et al.
Publicado: (2021)

Epigenetics in the Diagnosis and Therapy of Malignant Melanoma
por: Santourlidis, Simeon, et al.
Publicado: (2022)

Histone modifications and their role in epigenetics of atopy and allergic diseases
por: Alaskhar Alhamwe, Bilal, et al.
Publicado: (2018)

Current Epigenetic Insights in Kidney Development
por: Chan, Katrina, et al.
Publicado: (2021)

The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis
por: Muraca, Maurizio, et al.
Publicado: (2020)

Primary synovial sarcoma of kidney: A rare tumor with an atypical presentation
por: Dassi, Vimal, et al.
Publicado: (2009)

Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy
por: Fathi, Amir T., et al.
Publicado: (2012)

The Role of RNA Epigenetic Modification in Normal and Malignant Hematopoiesis
por: Vasic, Radovan, et al.
Publicado: (2020)

Tackling malignant melanoma epigenetically: histone lysine methylation
por: Orouji, Elias, et al.
Publicado: (2018)

Insights into novel emerging epigenetic drugs in myeloid malignancies
por: Chandhok, Namrata S., et al.
Publicado: (2019)

Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019)

Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies
por: Kumar, Subhasree, et al.
Publicado: (2020)

Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
por: Gaál, Zsuzsanna
Publicado: (2022)

Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation
por: An, Jungeun, et al.
Publicado: (2023)

Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
por: Sun, Jing, et al.
Publicado: (2017)

New insights on the role of epigenetic alterations in hepatocellular carcinoma
por: Frau, Maddalena, et al.
Publicado: (2014)

Malignant tumours of the kidney: imaging strategy
por: Smets, Anne M., et al.
Publicado: (2010)

The Role of Epigenetics in Neuroinflammatory-Driven Diseases
por: Giallongo, Sebastiano, et al.
Publicado: (2022)

Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis
por: Recillas-Targa, Felix, et al.
Publicado: (2006)

Hydrogen Sulfide: Emerging Role in Bladder, Kidney, and Prostate Malignancies
por: Akbari, Masoud, et al.
Publicado: (2019)

Critical role of the high mobility group A proteins in hematological malignancies
por: De Martino, Marco, et al.
Publicado: (2021)

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
por: Palanca-Ballester, Cora, et al.
Publicado: (2021)

Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes
por: Montaner-Angoiti, Esperanza, et al.
Publicado: (2023)

Epigenetics in normal and malignant hematopoiesis: An overview and update 2017
por: Goyama, Susumu, et al.
Publicado: (2017)

Kidney infiltration due to malignant lymphoma
por: Neild, G. H., et al.
Publicado: (2012)

Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease
por: Bowden, Sarah A., et al.
Publicado: (2021)

Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Lu, Heng-Cheng, et al.
Publicado: (2021)

Recent Advances in Epigenetics of Age-Related Kidney Diseases
por: Liu, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj2740crlqucg9p3339r98gp5m